153 related articles for article (PubMed ID: 35918773)
1. Fatal systemic disorder caused by biallelic variants in FARSA.
Kim SY; Ko S; Kang H; Kim MJ; Moon J; Lim BC; Kim KJ; Choi M; Choi HJ; Chae JH
Orphanet J Rare Dis; 2022 Aug; 17(1):306. PubMed ID: 35918773
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanyl-tRNA synthetase deficiency caused by biallelic variants in FARSA gene and literature review.
Guo R; Chen Y; Hu X; Qi Z; Guo J; Li Y; Hao C
BMC Med Genomics; 2023 Oct; 16(1):245. PubMed ID: 37833669
[TBL] [Abstract][Full Text] [Related]
3. FARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects.
Krenke K; Szczałuba K; Bielecka T; Rydzanicz M; Lange J; Koppolu A; Płoski R
Clin Genet; 2019 Nov; 96(5):468-472. PubMed ID: 31355908
[TBL] [Abstract][Full Text] [Related]
4. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease.
Antonellis A; Oprescu SN; Griffin LB; Heider A; Amalfitano A; Innis JW
Hum Mutat; 2018 Jun; 39(6):834-840. PubMed ID: 29573043
[TBL] [Abstract][Full Text] [Related]
5. FARS1-related disorders caused by bi-allelic mutations in cytosolic phenylalanyl-tRNA synthetase genes: Look beyond the lungs!
Schuch LA; Forstner M; Rapp CK; Li Y; Smith DEC; Mendes MI; Delhommel F; Sattler M; Emiralioğlu N; Taskiran EZ; Orhan D; Kiper N; Rohlfs M; Jeske T; Hastreiter M; Gerstlauer M; Torrent-Vernetta A; Moreno-Galdó A; Kammer B; Brasch F; Reu-Hofer S; Griese M
Clin Genet; 2021 Jun; 99(6):789-801. PubMed ID: 33598926
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy.
Elo JM; Yadavalli SS; Euro L; Isohanni P; Götz A; Carroll CJ; Valanne L; Alkuraya FS; Uusimaa J; Paetau A; Caruso EM; Pihko H; Ibba M; Tyynismaa H; Suomalainen A
Hum Mol Genet; 2012 Oct; 21(20):4521-9. PubMed ID: 22833457
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease.
Chen W; Rehsi P; Thompson K; Yeo M; Stals K; He L; Schimmel P; Chrzanowska-Lightowlers ZMA; Wakeling E; Taylor RW; Kuhle B
Mol Genet Metab; 2023 Nov; 140(3):107657. PubMed ID: 37523899
[TBL] [Abstract][Full Text] [Related]
8. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease.
Zadjali F; Al-Yahyaee A; Al-Nabhani M; Al-Mubaihsi S; Gujjar A; Raniga S; Al-Maawali A
Hum Mutat; 2018 Oct; 39(10):1355-1359. PubMed ID: 30014610
[TBL] [Abstract][Full Text] [Related]
9. FARS2 deficiency; new cases, review of clinical, biochemical, and molecular spectra, and variants interpretation based on structural, functional, and evolutionary significance.
Almannai M; Wang J; Dai H; El-Hattab AW; Faqeih EA; Saleh MA; Al Asmari A; Alwadei AH; Aljadhai YI; AlHashem A; Tabarki B; Lines MA; Grange DK; Benini R; Alsaman AS; Mahmoud A; Katsonis P; Lichtarge O; Wong LC
Mol Genet Metab; 2018 Nov; 125(3):281-291. PubMed ID: 30177229
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of mammalian phenylalanyl-tRNA synthetase upon phenylalanine restriction.
Lazard M; Mirande M; Waller JP
FEBS Lett; 1987 May; 216(1):27-30. PubMed ID: 3582665
[TBL] [Abstract][Full Text] [Related]
11. Impaired affinity for phenylalanine in Escherichia coli phenylalanyl-tRNA synthetase mutant caused by Gly-to-Asp exchange in motif 2 of class II tRNA synthetases.
Kast P; Wehrli C; Hennecke H
FEBS Lett; 1991 Nov; 293(1-2):160-3. PubMed ID: 1959653
[TBL] [Abstract][Full Text] [Related]
12. α-Phenylalanyl tRNA synthetase competes with Notch signaling through its N-terminal domain.
Ho MT; Lu J; Vazquez-Pianzola P; Suter B
PLoS Genet; 2022 Apr; 18(4):e1010185. PubMed ID: 35486661
[TBL] [Abstract][Full Text] [Related]
13. First Report of FARSA in the Regulation of Cell Cycle and Survival in Mantle Cell Lymphoma Cells via PI3K-AKT and FOXO1-RAG1 Axes.
Feng M; Yang K; Wang J; Li G; Zhang H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675119
[TBL] [Abstract][Full Text] [Related]
14. Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.
Li L; Ma J; Wang J; Dong L; Liu S
Eur J Med Res; 2022 Sep; 27(1):184. PubMed ID: 36155627
[TBL] [Abstract][Full Text] [Related]
15. FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System.
Li B; Liu F; Chen X; Chen T; Zhang J; Liu Y; Yao Y; Hu W; Zhang M; Wang B; Liu L; Chen K; Wu Y
Circulation; 2024 Apr; 149(16):1268-1284. PubMed ID: 38362779
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of phenylalanyl-tRNA synthetase complexed with phenylalanine and a phenylalanyl-adenylate analogue.
Reshetnikova L; Moor N; Lavrik O; Vassylyev DG
J Mol Biol; 1999 Apr; 287(3):555-68. PubMed ID: 10092459
[TBL] [Abstract][Full Text] [Related]
17. Phenylalanyl-tRNA synthetase contains a dispensable RNA-binding domain that contributes to the editing of noncognate aminoacyl-tRNA.
Roy H; Ibba M
Biochemistry; 2006 Aug; 45(30):9156-62. PubMed ID: 16866361
[TBL] [Abstract][Full Text] [Related]
18. Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns.
Finarov I; Moor N; Kessler N; Klipcan L; Safro MG
Structure; 2010 Mar; 18(3):343-53. PubMed ID: 20223217
[TBL] [Abstract][Full Text] [Related]
19. Prokaryotic and eukaryotic tetrameric phenylalanyl-tRNA synthetases display conservation of the binding mode of the tRNA(Phe) CCA end.
Moor N; Lavrik O; Favre A; Safro M
Biochemistry; 2003 Sep; 42(36):10697-708. PubMed ID: 12962494
[TBL] [Abstract][Full Text] [Related]
20. Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer.
Gao X; Guo R; Li Y; Kang G; Wu Y; Cheng J; Jia J; Wang W; Li Z; Wang A; Xu H; Jia Y; Li Y; Qi X; Wei Z; Wei C
J Gastroenterol Hepatol; 2021 Nov; 36(11):3113-3126. PubMed ID: 34159625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
